InsideArbitrage Event Driven Monitor – November 2, 2022
Quick updates on the event-driven strategies we follow on InsideArbitrage.
Merger Arbitrage
- Abiomed (ABMD) to be acquired by Johnson & Johnson (JNJ) for $16.6 billion. Under the terms of the agreement, shareholders of Abiomed will receive $380.00 per share in cash, along with one non-tradeable CVR that entitles them to up to an additional $35.00 per share in cash if certain clinical and commercial milestones are achieved.
- Atlas Corp. (ATCO) to be acquired by Poseidon Acquisition Corp. for $10.9 billion or $15.50 per share in cash.
- Benefitfocus (BNFT) to be acquired by Voya Financial (VOYA) for $570 million or $10.50 per share in cash.
Only plus or premium subscribers can access this post. Subscribe today.
